Retinal vascular occlusions

IU Scott, PA Campochiaro, NJ Newman, V Biousse - The Lancet, 2020 - thelancet.com
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …

Risk factors and treatment strategy for retinal vascular occlusive diseases

R Terao, R Fujino, T Ahmed - Journal of clinical medicine, 2022 - mdpi.com
Retinal occlusive diseases are common diseases that can lead to visual impairment. Retinal
artery occlusion and retinal vein occlusion are included in the clinical entity, but they have …

Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)

U Schmidt-Erfurth, J Garcia-Arumi, BS Gerendas… - …, 2019 - karger.com
The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …

Cardiovascular adverse events with intravitreal anti–vascular endothelial growth factor drugs: a systematic review and meta-analysis of randomized clinical trials

NN Ntjam, M Thulliez, G Paintaud, F Salvo… - JAMA …, 2021 - jamanetwork.com
Importance Systemic safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF)
is a matter of debate and regular updates are necessary. Objective To evaluate systemic …

Disorganization of retinal inner layers and ellipsoid zone disruption predict visual outcomes in central retinal vein occlusion

EW Chan, M Eldeeb, V Sun, D Thomas, A Omar… - Ophthalmology …, 2019 - Elsevier
Purpose To assess the associations and predictive value of spectral-domain (SD) OCT inner
and outer retinal structural parameters and visual acuity (VA) outcomes in macular edema …

Intravitreal dexamethasone implant as a sustained release drug delivery device for the treatment of ocular diseases: a comprehensive review of the literature

C Iovino, R Mastropasqua, M Lupidi, D Bacherini… - Pharmaceutics, 2020 - mdpi.com
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical
industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the …

[HTML][HTML] Intravitreal medications for retinal vein occlusion: systematic review and meta-analysis

A Lashay, H Riazi-Esfahani… - Journal of ophthalmic …, 2019 - ncbi.nlm.nih.gov
Purpose To evaluate the outcomes of different intravitreal injections for the treatment of
retinal vein occlusion including central retinal vein occlusion (CRVO) and branch retinal vein …

Real-world data: ranibizumab treatment for retinal vein occlusion in the OCEAN study

J Callizo, F Ziemssen, T Bertelmann… - Clinical …, 2019 - Taylor & Francis
Purpose The non-interventional OCEAN study (NCT02194803) evaluated frequency and
monitoring of ranibizumab injections for retinal vein occlusion (RVO) in routine practice in …

Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis

H Lin, Y Liu, SP Kambhampati, CC Hsu, RM Kannan… - The ocular …, 2018 - Elsevier
Purpose To investigate the efficacy of a single subconjunctival injection of dendrimer-
dexamethasone conjugate in a rabbit model of induced autoimmune dacryoadenitis (AID) …

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta …

L Xiaodong, X Xuejun - Journal of Ophthalmology, 2022 - Wiley Online Library
Purpose. The purpose of this meta‐analysis was to evaluate the efficacy and safety of
dexamethasone intravitreal implant (DEX) for the treatment of diabetic macular edema …